Followers | 43 |
Posts | 5751 |
Boards Moderated | 0 |
Alias Born | 04/12/2021 |

Sunday, October 17, 2021 4:40:48 PM
“6:16a ET 8/10/2021 - Benzinga
Nautilus Biotechnology Q2 EPS $(0.19) Misses $(0.09) Estimate
Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.09) by 111.11 percent.
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.”
my posts are always theory and not financial advice
Recent NAUT News
- Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award • GlobeNewswire Inc. • 11/30/2023 01:00:00 PM
- Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development • GlobeNewswire Inc. • 11/01/2023 12:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/31/2023 08:02:46 PM
- Nautilus Biotechnology Reports Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 10/31/2023 12:05:00 PM
- Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023 • GlobeNewswire Inc. • 10/11/2023 12:05:00 PM
- Nautilus Biotechnology to Participate in Upcoming September Investor Conferences • GlobeNewswire Inc. • 09/06/2023 11:30:00 AM
- Nautilus Biotechnology to Participate in Upcoming August Investor Conferences • GlobeNewswire Inc. • 08/04/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/02/2023 08:03:16 PM
- Nautilus Biotechnology Reports Second Quarter 2023 Financial Results • GlobeNewswire Inc. • 08/02/2023 11:30:00 AM
- Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023 • GlobeNewswire Inc. • 07/11/2023 01:23:03 PM
- Nautilus Biotechnology to Participate in Upcoming June Investor Conferences • GlobeNewswire Inc. • 05/24/2023 12:05:00 PM
- Nautilus Biotechnology Reports First Quarter 2023 Financial Results • GlobeNewswire Inc. • 05/02/2023 10:30:00 AM
- Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023 • GlobeNewswire Inc. • 04/18/2023 08:05:00 PM
- Nautilus Biotechnology to Participate in B. Riley Securities’ Disruptive Biotech Enabling Technologies – Proteomics, Virtual Conference • GlobeNewswire Inc. • 03/23/2023 12:00:00 PM
- Nautilus Biotechnology Announces “First Access Challenge” Winners • GlobeNewswire Inc. • 03/07/2023 01:00:00 PM
- Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2022 Financial Results • GlobeNewswire Inc. • 02/23/2023 11:05:00 AM
- Nautilus Biotechnology to Participate in the 43rd Annual Cowen Health Care Conference • GlobeNewswire Inc. • 02/21/2023 01:00:00 PM
- Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023 • GlobeNewswire Inc. • 01/26/2023 01:00:00 PM
- Nautilus Biotechnology Expands to San Diego • GlobeNewswire Inc. • 01/26/2023 12:45:00 PM
- Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG) • GlobeNewswire Inc. • 01/19/2023 01:00:00 PM
POET Technologies Announces Pricing of US$1.4 Million Underwritten Public Offering of Common Shares and Warrants • POET • Dec 1, 2023 10:17 AM
CGrowth Capital Inc. Sets Stage for Exciting 2024 with Savage Barbell Apparel Expansion • CGRA • Nov 28, 2023 11:15 AM
Immix Biopharma Announces FDA Approval of IND Application for CAR-T NXC-201, Enabling U.S. Patient Dosing • IMMX • Nov 28, 2023 10:48 AM
Swifty Global Secures GLI Certification for New Cutting-Edge B2B Gaming Platform • DRCR • Nov 28, 2023 9:15 AM
Nate's Food Co. Successfully Obtains GACC Registration in China, Paving the Way for Contract Execution on Commodities • NHMD • Nov 28, 2023 8:00 AM
Mass Megawatts Announces LOWEST PRICE GUARANTEE on Solar Project Sales and Further Cost Reductions Using our Patent Pending Technologies • MMMW • Nov 28, 2023 8:00 AM